Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 108

    1.

    Report from the 1st International NOD Mouse T-Cell Workshop and the follow-up mini-workshop.

    Kaufman DL, Tisch R, Sarvetnick N, Chatenoud L, Harrison LC, Haskins K, Quinn A, Sercarz E, Singh B, von Herrath M, Wegmann D, Wen L, Zekzer D.

    Diabetes. 2001 Nov;50(11):2459-63. Review.PMID: 11679422 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    The second murine autoantibody workshop: remarkable interlaboratory concordance for radiobinding assays to identify insulin autoantibodies in nonobese diabetic mice.

    Yu L, Eisenbarth G, Bonifacio E, Thomas J, Atkinson M, Wasserfall C.

    Ann N Y Acad Sci. 2003 Nov;1005:1-12.PMID: 14679035 [PubMed - indexed for MEDLINE]Related articles

    5.
    6.

    Comparison of cytokine ELISpot assay formats for the detection of islet antigen autoreactive T cells. Report of the third immunology of diabetes society T-cell workshop.

    Schloot NC, Meierhoff G, Karlsson Faresjö M, Ott P, Putnam A, Lehmann P, Gottlieb P, Roep BO, Peakman M, Tree T.

    J Autoimmun. 2003 Dec;21(4):365-76.PMID: 14624759 [PubMed - indexed for MEDLINE]Related articles

    7.

    HLA-DQ-regulated T-cell responses to islet cell autoantigens insulin and GAD65.

    Tree TI, Duinkerken G, Willemen S, de Vries RR, Roep BO.

    Diabetes. 2004 Jul;53(7):1692-9.PMID: 15220192 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Detection of GAD65-reactive T-Cells in type 1 diabetes by immunoglobulin-free ELISPOT assays.

    Kotani R, Nagata M, Moriyama H, Nakayama M, Yamada K, Chowdhury SA, Chakrabarty S, Jin Z, Yasuda H, Yokono K.

    Diabetes Care. 2002 Aug;25(8):1390-7.PMID: 12145240 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Immunological characterization and therapeutic activity of an altered-peptide ligand, NBI-6024, based on the immunodominant type 1 diabetes autoantigen insulin B-chain (9-23) peptide.

    Alleva DG, Gaur A, Jin L, Wegmann D, Gottlieb PA, Pahuja A, Johnson EB, Motheral T, Putnam A, Crowe PD, Ling N, Boehme SA, Conlon PJ.

    Diabetes. 2002 Jul;51(7):2126-34.PMID: 12086942 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    A peptide of glutamic acid decarboxylase 65 can recruit and expand a diabetogenic T cell clone, BDC2.5, in the pancreas.

    Dai YD, Jensen KP, Lehuen A, Masteller EL, Bluestone JA, Wilson DB, Sercarz EE.

    J Immunol. 2005 Sep 15;175(6):3621-7.PMID: 16148106 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Prevention of autoimmune diabetes by immunogene therapy using recombinant vaccinia virus expressing glutamic acid decarboxylase.

    Jun HS, Chung YH, Han J, Kim A, Yoo SS, Sherwin RS, Yoon JW.

    Diabetologia. 2002 May;45(5):668-76. Epub 2002 Apr 4.PMID: 12107747 [PubMed - indexed for MEDLINE]Related articles

    12.

    CD4(+) T cells from glutamic acid decarboxylase (GAD)65-specific T cell receptor transgenic mice are not diabetogenic and can delay diabetes transfer.

    Tarbell KV, Lee M, Ranheim E, Chao CC, Sanna M, Kim SK, Dickie P, Teyton L, Davis M, McDevitt H.

    J Exp Med. 2002 Aug 19;196(4):481-92.PMID: 12186840 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Spontaneous peripheral T-cell responses to the IA-2beta (phogrin) autoantigen in young nonobese diabetic mice.

    Achenbach P, Kelemen K, Wegmann DR, Hutton JC.

    J Autoimmun. 2002 Nov;19(3):111-6.PMID: 12419281 [PubMed - indexed for MEDLINE]Related articles

    14.

    T cells to a dominant epitope of GAD65 express a public CDR3 motif.

    Quinn A, McInerney M, Huffman D, McInerney B, Mayo S, Haskins K, Sercarz E.

    Int Immunol. 2006 Jun;18(6):967-79. Epub 2006 Apr 26.PMID: 16641112 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    DNA vaccination with heat shock protein 60 inhibits cyclophosphamide-accelerated diabetes.

    Quintana FJ, Carmi P, Cohen IR.

    J Immunol. 2002 Nov 15;169(10):6030-5.PMID: 12421990 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Induction of autoantigen-specific Th2 and Tr1 regulatory T cells and modulation of autoimmune diabetes.

    Chen C, Lee WH, Yun P, Snow P, Liu CP.

    J Immunol. 2003 Jul 15;171(2):733-44.PMID: 12847240 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    CD8+ T lymphocytes specific for glutamic acid decarboxylase 90-98 epitope mediate diabetes in NOD SCID mouse.

    Sévère S, Gauvrit A, Vu AT, Bach JM.

    Mol Immunol. 2007 Apr;44(11):2950-60. Epub 2007 Mar 2.PMID: 17336387 [PubMed - indexed for MEDLINE]Related articles

    18.

    B cells are crucial for determinant spreading of T cell autoimmunity among beta cell antigens in diabetes-prone nonobese diabetic mice.

    Tian J, Zekzer D, Lu Y, Dang H, Kaufman DL.

    J Immunol. 2006 Feb 15;176(4):2654-61.PMID: 16456028 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Peptide-pulsed immature dendritic cells reduce response to beta cell target antigens and protect NOD recipients from type I diabetes.

    Lo J, Peng RH, Barker T, Xia CQ, Clare-Salzler MJ.

    Ann N Y Acad Sci. 2006 Oct;1079:153-6.PMID: 17130547 [PubMed - indexed for MEDLINE]Related articles

    20.

    CD4+CD25+ regulatory T cells generated in response to insulin B:9-23 peptide prevent adoptive transfer of diabetes by diabetogenic T cells.

    Mukherjee R, Chaturvedi P, Qin HY, Singh B.

    J Autoimmun. 2003 Nov;21(3):221-37.PMID: 14599847 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data